Goodwin advised Theseus Pharmaceuticals on the sale to Concentra Biosciences, assisted by Gibson, Dunn & Crutcher LLP. Leerink Partners acted as Theseus’ financial advisor. Theseus Pharmaceuticals,...
Concentra Biosciences’ $185 Million Acquisition of Theseus Pharmaceuticals
Theseus Pharmaceuticals’ $160 Million IPO
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Theseus Pharmaceuticals on the deal. Theseus Pharmaceuticals, Inc., a biopharmaceutical company focused on improving the lives of cancer...